| Intrinsic Valuation of: DIVISLAB | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 93 | Market Cap | ₹1,795B | |||||
| 2021 | - | - (-) | P/E Ratio | 72 | Total Asset | ₹169B | |||||
| 2022 | ₹12B | - (-) | Net Income | ₹22B | Total Debt | ₹0 | |||||
| 2023 | ₹20B | 65.7% (90.2%) | EBITDA | ₹33B | Total Liab | ₹20B | |||||
| 2024 | ₹3B | -87.0% (-87.2%) | Opr Margin | 27.57 | Debt/Equity | - | |||||
| 2025 | ₹2B | -16.7% (-30.3%) | PreTax Margin | 27.55 | BV/Share | 564 | |||||
| 5Y Average FCF | ₹9B | 2.8% (-9.1%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.00% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (2.8%) | ||||||||||
| 2026 | ₹4B | MBG Intrinsic Value | ₹834 | ||||||||
| 2027 | ₹4B | ||||||||||
| 2028 | ₹5B | ||||||||||
| 2029 | ₹5B | ||||||||||
| 2030 | ₹5B | ||||||||||
| 2031 | ₹5B | ||||||||||
| Terminal Value | ₹113B | Net Worth/Share | ₹564 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹97B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹4B | ₹382 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹0 | WACC | 6.5% | 360 | 390 | 427 | 476 | 540 | |||
| Equity Value | ₹101B | 7.1% | 322 | 344 | 372 | 407 | 451 | ||||
| Shares Outstanding | 265,468,580 | 7.8% | 291 | 308 | 330 | 355 | 387 | ||||
| 8.4% | 265 | 280 | 296 | 316 | 339 | ||||||
| DCF Intrinsic Value | ₹382 | 9.0% | 245 | 256 | 269 | 285 | 303 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||